Matches in Nanopublications for { ?s ?p "[Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor, is in wide clinical use for the treatment and prevention of liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion description "[Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor, is in wide clinical use for the treatment and prevention of liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_provenance.
- NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_assertion description "[Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor, is in wide clinical use for the treatment and prevention of liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.